Recruiting studies: Opioid Withdrawal Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826 Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Phase 3 · 6 location(s) · Emory University · NCT05834478 Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
Phase 2 · 1 location(s) · University of Calgary · NCT04939623 Evaluating Buspirone to Treat Opioid Withdrawal
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT05511909 Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT05027919 CEDRN: Opioid Registry
Phase N/A · 1 location(s) · University of British Columbia · NCT07466784 Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
NA · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05555485 A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for t
NA · 4 location(s) · OpiAID · NCT07405398 Cannabis and Opioid Use Disorder
Phase 1 · 1 location(s) · Shanna Babalonis, PhD · NCT05729932 Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Phase N/A · 2 location(s) · Spark Biomedical, Inc. · NCT06487533 Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
NA · 1 location(s) · Nu Eyne Co., Ltd. · NCT07079215 Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
Phase 3 · 1 location(s) · Washington University School of Medicine · NCT05790252 MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
Phase N/A · 1 location(s) · Milton S. Hershey Medical Center · NCT05937594 Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disor
Phase 1 · 1 location(s) · Proniras Corporation · NCT06538558

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.